IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,547,000 | +8.0% | 520,000 | 0.0% | 0.77% | +15.2% |
| Q4 2021 | $6,063,000 | -10.7% | 520,000 | 0.0% | 0.67% | -14.5% |
| Q3 2021 | $6,791,000 | +1.5% | 520,000 | 0.0% | 0.78% | +6.8% |
| Q2 2021 | $6,692,000 | +15.1% | 520,000 | 0.0% | 0.74% | +5.5% |
| Q1 2021 | $5,814,000 | +1.7% | 520,000 | +3.6% | 0.70% | -20.9% |
| Q4 2020 | $5,716,000 | +26.6% | 501,874 | 0.0% | 0.88% | +7.6% |
| Q3 2020 | $4,514,000 | +6.8% | 501,874 | +22.6% | 0.82% | +6.1% |
| Q2 2020 | $4,226,000 | +946.0% | 409,500 | +923.8% | 0.77% | +841.5% |
| Q1 2020 | $404,000 | +344.0% | 40,000 | +378.6% | 0.08% | +583.3% |
| Q2 2019 | $91,000 | – | 8,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |